Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Treg cells

Another startup, another planet: Alderaan closes $21M A round for anti-CD25 antibodies

Jan. 9, 2020

By Cormac Sheridan

Alderaan Biotechnology SAS is the latest contender to enter the hotly contested world of regulatory T-cell (Treg) depletion in cancer.

Blueprint releases topline data for pralsetinib in RET fusion-positive NSCLC

Jan. 9, 2020

Merck & Co. identifies new arginase inhibitors

Jan. 9, 2020

Abbisko Therapeutics divulges FGFR-1 and/or FGFR-2 inhibitors

Jan. 9, 2020

SR-4835, a novel CDK12/13 dual inhibitor for treating triple-negative breast cancer

Jan. 9, 2020

FDA clears IND for ADXS-504 as treatment of prostate cancer

Jan. 9, 2020

CohBar discovers novel peptide inhibitors of CXCR4

Jan. 9, 2020

Preliminary data from phase III ASCERTAIN study of ASTX-727

Jan. 9, 2020

First-in-human data published for the pan-PIM kinase inhibitor PIM-447

Jan. 9, 2020

Researchers report identification of TQ-05310, a novel potent mutant IDH2 inhibitor

Jan. 9, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 29, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Chinese biotechs gain leverage as partners in dealmaking
BioWorld
China’s biotech ecosystem has crossed an inflection point, and Chinese biotechs are gaining leverage in dealmaking, executives from multinational companies said...
Plasticity, properly parsed, provides psychiatric platform
BioWorld
If Benjamin Braddock, of The Graduate fame, were a young neuroscientist in the 21st century instead of a liberal arts graduate in 1967, the advice he received...
Roche identifies new TREM2 agonists
BioWorld Science
F. Hoffmann-La Roche Ltd. and Hoffmann-La Roche Inc. have prepared and tested new compounds acting as triggering receptor expressed on myeloid cells 2 (TREM2)...